Infection of human airway epithelia by SARS coronavirus is associated with ACE2 expression and localization.
作者信息
Jia Hong Peng, Look Dwight C, Hickey Melissa, Shi Lei, Pewe Lecia, Netland Jason, Farzan Michael, Wohlford-Lenane Christine, Perlman Stanley, McCray Paul B
机构信息
University of Iowa, Iowa City 52242, USA.
出版信息
Adv Exp Med Biol. 2006;581:479-84. doi: 10.1007/978-0-387-33012-9_85.
Abstract
摘要
相似文献
1
Infection of human airway epithelia by SARS coronavirus is associated with ACE2 expression and localization.
Adv Exp Med Biol. 2006;581:479-84. doi: 10.1007/978-0-387-33012-9_85.
2
Insights from the association of SARS-CoV S-protein with its receptor, ACE2.
Adv Exp Med Biol. 2006;581:209-18. doi: 10.1007/978-0-387-33012-9_36.
3
Cellular entry of the SARS coronavirus.
Trends Microbiol. 2004 Oct;12(10):466-72. doi: 10.1016/j.tim.2004.08.008.
4
ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia.
J Virol. 2005 Dec;79(23):14614-21. doi: 10.1128/JVI.79.23.14614-14621.2005.
5
Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63.
J Virol. 2010 Jan;84(2):1198-205. doi: 10.1128/JVI.01248-09. Epub 2009 Oct 28.
6
Severe acute respiratory syndrome coronavirus entry as a target of antiviral therapies.
Antivir Ther. 2007;12(4 Pt B):639-50.
7
Structural biology. Adaptation of SARS coronavirus to humans.
Science. 2005 Sep 16;309(5742):1822-3. doi: 10.1126/science.1118817.
8
Severe acute respiratory syndrome coronavirus entry into host cells: Opportunities for therapeutic intervention.
Med Res Rev. 2006 Jul;26(4):414-33. doi: 10.1002/med.20055.
9
Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2.
J Virol. 2010 Dec;84(24):12658-64. doi: 10.1128/JVI.01542-10. Epub 2010 Oct 6.
10
Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease.
J Virol. 2011 Dec;85(24):13363-72. doi: 10.1128/JVI.05300-11. Epub 2011 Oct 12.
引用本文的文献
1
Impact of COVID-19 on Pediatric Inflammatory Bowel Diseases-From Expectations to Reality.
J Pers Med. 2024 Apr 9;14(4):399. doi: 10.3390/jpm14040399.
2
Advanced approaches to overcome biological barriers in respiratory and systemic routes of administration for enhanced nucleic acid delivery to the lung.
Expert Opin Drug Deliv. 2023 Jul-Dec;20(11):1531-1552. doi: 10.1080/17425247.2023.2282535. Epub 2023 Dec 20.
3
Mesenchymal stem cells: a new front emerges in coronavirus disease 2019 treatment.
Cytotherapy. 2022 Aug;24(8):755-766. doi: 10.1016/j.jcyt.2020.07.002. Epub 2020 Jul 15.
4
Goblet Cell Hyperplasia Increases SARS-CoV-2 Infection in Chronic Obstructive Pulmonary Disease.
Microbiol Spectr. 2022 Aug 31;10(4):e0045922. doi: 10.1128/spectrum.00459-22. Epub 2022 Jul 13.
5
Calcium Signaling Pathway Is Involved in the Shedding of ACE2 Catalytic Ectodomain: New Insights for Clinical and Therapeutic Applications of ACE2 for COVID-19.
Biomolecules. 2022 Jan 5;12(1):76. doi: 10.3390/biom12010076.
6
Pathogenesis, Symptomatology, and Transmission of SARS-CoV-2 through Analysis of Viral Genomics and Structure.
mSystems. 2021 Oct 26;6(5):e0009521. doi: 10.1128/mSystems.00095-21.
7
Implications of SARS-COV-2 infection in the diagnosis and management of the pediatric gastrointestinal disease.
Ital J Pediatr. 2021 Mar 24;47(1):71. doi: 10.1186/s13052-021-01020-9.
8
Pathogenesis, Symptomatology, and Transmission of SARS-CoV-2 through Analysis of Viral Genomics and Structure.
ArXiv. 2021 Feb 1:arXiv:2102.01521v4.
9
The soluble catalytic ectodomain of ACE2 a biomarker of cardiac remodelling: new insights for heart failure and COVID19.
Heart Fail Rev. 2021 Jul;26(4):961-971. doi: 10.1007/s10741-020-10066-6. Epub 2021 Jan 6.
10
Goblet Cell Hyperplasia Increases SARS-CoV-2 Infection in COPD.
bioRxiv. 2020 Nov 12:2020.11.11.379099. doi: 10.1101/2020.11.11.379099.
本文引用的文献
1
Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry.
Proc Natl Acad Sci U S A. 2005 May 31;102(22):7988-93. doi: 10.1073/pnas.0409465102. Epub 2005 May 16.
2
Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2.
EMBO J. 2005 Apr 20;24(8):1634-43. doi: 10.1038/sj.emboj.7600640. Epub 2005 Mar 24.
3
CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus.
Proc Natl Acad Sci U S A. 2004 Nov 2;101(44):15748-53. doi: 10.1073/pnas.0403812101. Epub 2004 Oct 20.
4
DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus.
J Virol. 2004 Nov;78(21):12090-5. doi: 10.1128/JVI.78.21.12090-12095.2004.
5
Highly infectious SARS-CoV pseudotyped virus reveals the cell tropism and its correlation with receptor expression.
Biochem Biophys Res Commun. 2004 Sep 3;321(4):994-1000. doi: 10.1016/j.bbrc.2004.07.060.
6
Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis.
J Pathol. 2004 Jun;203(2):631-7. doi: 10.1002/path.1570.
7
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.
Nature. 2003 Nov 27;426(6965):450-4. doi: 10.1038/nature02145.
8
Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore.
Hum Pathol. 2003 Aug;34(8):743-8. doi: 10.1016/s0046-8177(03)00367-8.
9
Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong.
Lancet. 2003 May 24;361(9371):1761-6. doi: 10.1016/S0140-6736(03)13410-1.
10
Identification of severe acute respiratory syndrome in Canada.
N Engl J Med. 2003 May 15;348(20):1995-2005. doi: 10.1056/NEJMoa030634. Epub 2003 Mar 31.
Zotero 插件